These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8239562)

  • 21. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle insulin resistance in myotonic dystrophy: effect of supraphysiologic insulinization.
    Moxley RT; Griggs RC; Goldblatt D
    Neurology; 1980 Oct; 30(10):1077-83. PubMed ID: 6999379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective disappearance of medial back muscles in a case of myotonic dystrophy type 1.
    Morihara R; Hishikawa N; Yamashita T; Deguchi K; Kurata T; Abe K
    J Neurol Sci; 2015; 353(1-2):185-6. PubMed ID: 25940325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spinal muscular atrophy combined with myotonic dystrophy].
    Wendland KL
    J Neurol Sci; 1974 Feb; 21(2):191-5. PubMed ID: 4443820
    [No Abstract]   [Full Text] [Related]  

  • 25. Content of methylhistidines in normal and pathological human skeletal muscles.
    Mussini E; Cornelio F; Dworzak F; Cotellessa L; Morandi L; Colombo L; De Ponte G; Marcucci F
    Muscle Nerve; 1983; 6(6):423-9. PubMed ID: 6621612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of testosterone in myotonic dystrophy.
    Griggs RC; Pandya S; Florence JM; Brooke MH; Kingston W; Miller JP; Chutkow J; Herr BE; Moxley RT
    Neurology; 1989 Feb; 39(2 Pt 1):219-22. PubMed ID: 2521699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic studies in muscular dystrophy: a role for insulin.
    Moxley RT
    Adv Neurol; 1977; 17():161-73. PubMed ID: 888734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of the rate of myofibrillar protein degradation using the arteriovenous difference in plasma 3-methylhistidine concentration of rats.
    Sugawara T; Ito Y; Nishizawa N; Suzuki H; Kobayashi H; Nagasawa T
    J Nutr Sci Vitaminol (Tokyo); 2009 Aug; 55(4):381-4. PubMed ID: 19763041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle wasting in emphysema.
    Morrison WL; Gibson JN; Scrimgeour C; Rennie MJ
    Clin Sci (Lond); 1988 Oct; 75(4):415-20. PubMed ID: 3197374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aqueous humor flow and flare in patients with myotonic dystrophy.
    Khan AR; Brubaker RF
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3131-9. PubMed ID: 8407221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin decreases muscle protein loss after operative trauma in man.
    Inculet RI; Finley RJ; Duff JH; Pace R; Rose C; Groves AC; Woolf LI
    Surgery; 1986 Jun; 99(6):752-8. PubMed ID: 3086996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular adrenergic receptor responses in skeletal muscle in myotonic dystrophy.
    Mechler F; Mastaglia FL
    Ann Neurol; 1981 Feb; 9(2):157-62. PubMed ID: 7235630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism].
    Beylot M; Riou JP; Sautot G; Mornex R
    Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breathing during sleep in patients with myotonic dystrophy and non-myotonic respiratory muscle weakness.
    Gilmartin JJ; Cooper BG; Griffiths CJ; Walls TJ; Veale D; Stone TN; Osselton JW; Hudgson P; Gibson GJ
    Q J Med; 1991 Jan; 78(285):21-31. PubMed ID: 1670061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of testosterone on muscle protein synthesis in myotonic dystrophy.
    Griggs RC; Halliday D; Kingston W; Moxley RT
    Ann Neurol; 1986 Nov; 20(5):590-6. PubMed ID: 2431651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An automatic method for determination of urinary and myofibrillar 3-methylhistidine: fractional rate of myofibrillar protein breakdown in rats fed on casein as source of protein.
    Martínez JA; Larralde J
    Rev Esp Fisiol; 1984 Mar; 40(1):103-7. PubMed ID: 6463336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electrocardiographic changes in some muscular diseases (excluding progressive dystrophy). Preliminary report].
    Slucka C; Kujawa H
    Neurol Neurochir Psychiatr Pol; 1965; 15(5):691-4. PubMed ID: 5861422
    [No Abstract]   [Full Text] [Related]  

  • 38. Shank sign in myotonic dystrophy type-1 (DM-1).
    Pradhan S
    J Clin Neurosci; 2007 Jan; 14(1):27-32. PubMed ID: 17092719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.
    Tarnopolsky M; Mahoney D; Thompson T; Naylor H; Doherty TJ
    Muscle Nerve; 2004 Jan; 29(1):51-8. PubMed ID: 14694498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.